• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Neerja Bhatla, Vanita Suri, +5 authors Hans Ludwig Bock
  • Medicine
  • The journal of obstetrics and gynaecology…
  • 2010 (First Publication: 1 February 2010)
  • AIM India has the highest number of annual incident cases and mortality rates for cervical cancer worldwide. This study was conducted to assess the immunogenicity and safety of human papillomavirusContinue Reading
  • Somsak Lolekha, W Tanthiphabha, +7 authors Hans Ludwig Bock
  • Biology, Medicine
  • The American journal of tropical medicine and…
  • 2001 (First Publication: 1 March 2001)
  • Blood samples were collected from healthy subjects, aged 9 months-29 years in urban and rural communities from 4 distinct regions in Thailand, to determine the seroprevalence rate of varicella-zosterContinue Reading
  • K. Zaman, David A Sack, +10 authors Hans Ludwig Bock
  • Medicine
  • Vaccine
  • 2009 (First Publication: 1 February 2009)
  • Co-administration of oral live-attenuated human rotavirus vaccine RIX4414 (Rotarix) and oral polio vaccine (OPV) was assessed. Healthy infants were randomised to receive 2-doses of either: RIX4414 orContinue Reading
  • Roger Clemens, Chutima Pramoolsinsap, Robin G. Lorenz, Sasithon Pukrittayakamee, Hans Ludwig Bock, Nicholas J White
  • Medicine
  • British journal of haematology
  • 1994 (First Publication: 1 May 1994)
  • The mechanisms involved in the activation of the coagulation cascade in severe falciparum malaria were studied in 22 adult patients (19 male, three female) aged 18-45 (mean +/- SD 31 +/- 11) years.Continue Reading
  • Kong Boo Phua, Seng Hock Quak, +5 authors Hans Ludwig Bock
  • Medicine
  • The Journal of infectious diseases
  • 2005 (First Publication: 1 September 2005)
  • BACKGROUND At present, no rotavirus vaccine is commercially available for use worldwide. Hence, a live, attenuated monovalent vaccine was developed with human strain RIX4414 (G1P1A P[8] specificity).Continue Reading